Surgical planning console with pelvic CT scans looking into operating theater

SPHINCTER-PRESERVATION & PRECISION SURGERY

Advanced Colorectal Cancer Care in China

Colorectal cancer care requires high surgical radicality paired with meticulous preservation of natural bowel and urinary function. Chinese surgical teams perform the world’s largest volume of robotic ultra-low rectal resections, routinely sparing the anal sphincter and helping patients avoid permanent stoma bags even in tumors very close to the anus.

ADVANCED TREATMENT OPTIONS

Key Colorectal Cancer Treatments

Da Vinci robotic ultra-low resection, simultaneous liver metastasis removal, and targeted oral medications.

Sphincter-Saving Robotic Surgery

Da Vinci robotic ultra-low resection that completely removes rectal tumors while protecting nerves and sphincter muscles, avoiding permanent colostomy bags.

Liver Metastasis Coordinated Care

Coordinated simultaneous resection or ablation of liver metastases alongside bowel tumor removal, turning advanced cases into potential cures.

Targeted Oral Medications

Access to approved targeted therapies (such as Fruquintinib) combined with immunotherapy for refractory bowel and colorectal tumors.

WHY CHOOSE US

Why Choose China for Colorectal Cancer

A specialized clinical continuum connecting international patients with China's highest-volume colorectal cancer centers.

China’s colorectal oncology centers are international pioneers in function-preserving colorectal surgery. High surgical caseloads have refined minimally invasive and robotic techniques (including taTME and ISR), achieving sphincter preservation in over 85% of ultra-low rectal cancer patients where standard global guidelines previously recommended permanent stomas.

In advanced disease with liver spread, joint hepatobiliary and colorectal boards design synchronized treatment pathways combining arterial infusion, surgical resection, and novel targeted drugs. All treatment is delivered in top Grade 3A academic centers with transparent hospital pricing.

HOW IT WORKS

4 Steps to Treatment in China

A simple, step-by-step process from initial record review to your arrival and treatment in China.

01. Submit Records Online

Upload existing pathology reports, biomarker NGS profiles, and imaging scans through our secure clinical intake portal.

02. Pre-Screen & Doctor Match

Clinical eligibility and contraindication screening, matching your specific case with China's foremost oncology chiefs.

03. Doctor Consultation

One-on-one remote video consultation or written multidisciplinary assessment to confirm treatment protocol before travel.

04. Travel to China & Care

Expedited medical visa support, priority hospital admission, dedicated bilingual bedside escorts, and continuum follow-up.

PATIENT FAQS

Frequently Asked Questions

Key clinical, financial, and logistical insights for international patients considering care in China.
In most cases, yes. Advanced robotic ultra-low resection and intersphincteric dissection techniques allow skilled Chinese surgeons to preserve natural bowel control even when tumors are within 3 to 5 cm of the anal verge.
Simultaneous robotic surgery, hepatic artery infusion chemotherapy (HAIC), and precision microwave ablation can eliminate both primary and liver lesions in coordinated sessions.
Innovative targeted VEGFR inhibitors such as Fruquintinib, alongside anti-EGFR and PD-1 therapies, are routinely available.
Patients typically stay 5 to 7 days in the hospital, benefiting from enhanced recovery protocols (ERAS) that encourage rapid return to normal eating and movement.

CONFIDENTIAL CASE EVALUATION

Start with a Confidential Clinical Case Review

Submit your basic case details below for an initial eligibility review. Our medical team coordinates directly with chief oncologists at top Chinese cancer centers, returning a preliminary assessment and roadmap within 24–48 hours.

✓ Free initial triage  •  ✓ Direct specialist coordination  •  ✓ 100% Confidential

    Colorectal Cancer